Compare CNX & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CNX | SHC |
|---|---|---|
| Founded | 1860 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical Specialities |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.6B |
| IPO Year | 1998 | 2020 |
| Metric | CNX | SHC |
|---|---|---|
| Price | $32.80 | $15.50 |
| Analyst Decision | Sell | Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $35.71 | $20.33 |
| AVG Volume (30 Days) | 1.5M | ★ 2.3M |
| Earning Date | 04-30-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 763.33 | 68.75 |
| EPS | ★ 2.18 | 0.09 |
| Revenue | ★ $2,239,134,000.00 | $1,163,617,000.00 |
| Revenue This Year | N/A | $7.51 |
| Revenue Next Year | $11.14 | $6.00 |
| P/E Ratio | ★ $15.32 | $178.22 |
| Revenue Growth | ★ 76.76 | 5.74 |
| 52 Week Low | $27.72 | $10.94 |
| 52 Week High | $43.62 | $19.85 |
| Indicator | CNX | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 36.92 | 45.64 |
| Support Level | $31.52 | $15.00 |
| Resistance Level | $34.00 | $16.47 |
| Average True Range (ATR) | 0.90 | 0.52 |
| MACD | 0.08 | -0.00 |
| Stochastic Oscillator | 29.71 | 34.64 |
CNX Resources Corp is an independent natural gas development, production, midstream and technology company centered in the Appalachian Basin. It is focused on unconventional shale formations, prominently the Marcellus Shale and Utica Shale, in Pennsylvania, Ohio and West Virginia. Additionally, the company operates and develops Coalbed Methane (CBM) properties in Virginia. the company has two reportable segments: Shale and Coalbed Methane. The majority of the company's revenue is derived from the Shale segment.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.